In a recent development, Tillomed Laboratories Limited has issued a product recall for a specific batch of Labetalol 200mg Tablets.
Discover our latest podcast
Labetalol is a medication that is used to treat patients with high blood pressure. According to Medline Plus, it works by:
Relaxing blood vessels and slowing heart rate to improve blood flow and decrease blood pressure.
The recall is due to an error on the foil blister packaging, which incorrectly states Labetalol 100mg Tablets instead of the correct strength of Labetalol 200mg Tablets.
Read on to find out more about theaffected products and the proper guidance for both healthcare professionals and patients.
Which product has been affected?
The affected product is Labetalol 200mg Tablets, with the following details, as per GOV.UK:
- Company Name: Tillomed Laboratories Limited
- Product Name: Labetalol 200mg Tablets, PL 11311/0376
- Batch Number: 221345
- Expiry Date: 08/2025
- Pack Size: 56 (4x14)
- First Distributed: 15/05/2023
- Active Pharmaceutical Ingredient: Labetalol hydrochloride
- SNOMED Code: 36537111000001109
Guidance for healthcare professionals that bought the product:
If you have the product mentioned above, immediately stop supplying the batch. If you have any remaining stock of the product, be sure to isolate it and return it to your supplier.
The Defective Medicines Report Centre asks professionals to:
exercise their professional judgement to supply the correct pack, however there is no impact to the overall tablet
Adding:
If the prescription was written within the last 6 months, pharmacists can arrange for dispensing a pack that does not contain the incorrect blister foil labelling.
Read more: Here's the medication you should be careful of taking during a heatwave
Guidance for patients that were prescribed with the product:
If you are a patient who has been prescribed Labetalol 200mg Tablets and the foil blister inside your pack incorrectly states Labetalol 100mg, rest assured that you do have the right medicine as per your prescription.
However, patients who have received an incorrectly labeled blister which does not match the prescription you received, have been advised to contact their pharmacist for a replacement package. The statement issued by the DMRC also notes:
If the prescription was written within the last 6 months, the pharmacist can provide a pack without the incorrect blister foil labelling. Otherwise, consult your GP for a further prescription.
Patients who are feeling any reactions to taking the medicine have been asked to get in touch with a medical professional.
For more details you can consult GOV.UK
Read more:
⋙ Massive recall issued on snacks over undeclared allergens: Here are the affected products
⋙ Recalled eye drops cause yet another death in the US: Which products have been affected?
Sources used:
